MétaCan
Menu
Back to cohort

Abstract A04: Cross-species analysis identifies MUS81, a structure-specific endonuclease, as a novel synthetic lethal interaction with PARP

2017· article· en· W2767374855 on OpenAlexaff
Melanie L. Bailey, Nigel J. O’Neil, Philip Hieter

Bibliographic record

VenueMolecular Cancer Therapeutics · 2017
Typearticle
Languageen
FieldMedicine
TopicPARP inhibition in cancer therapy
Canadian institutionsUniversity of British Columbia
Fundersnot available
KeywordsBiologySynthetic lethalityOlaparibPARP inhibitorPoly ADP ribose polymeraseHomologous recombinationDNA repairGeneticsCell biologyDNA damageMolecular biologyPolymeraseDNA

Abstract

fetched live from OpenAlex

Abstract Recently, the inhibition of poly ADP-ribose polymerase, or PARP, in BRCA-mutated cells has been exploited as a therapeutic strategy for cancer due to the strong PARP/BRCA synthetic lethal relationship. Evidence suggests this lethality is likely due to DNA repair defects; however, details of this mechanism remain unclear. To this end, we sought to identify a larger spectrum of genes whose mutation renders cells sensitive to PARP inhibition. Using the model organism Caenorhabditis elegans, we developed an in vivo variomics approach to screen mutated C. elegans strains for sensitivity to the PARP inhibitor olaparib. Multiple sensitive strains contained mutations in either mus-81 or eme-1, two genes that form a heterodimeric DNA endonuclease complex involved in both stalled fork cleavage in replication and Holliday junction resolution in homologous recombination repair. Further investigation revealed that olaparib treatment caused somatic proliferation defects and anaphase bridges in mus-81 mutants. We found the MUS81/PARP genetic interaction from C. elegans to be conserved in human cells. Compared to MUS81 wild-type cell lines, MUS81 knockout cells showed a significant decrease in proliferation after exposure to PARP inhibitor and had characteristics distinct from olaparib-treated BRCA2 knockout cells. Surprisingly, cells that were lacking MUS81 and treated with PARP inhibitor showed a lack of apoptosis, dramatic increase in tetraploidy and higher incidence of anaphase bridges in mitosis. Using cross-species approaches, we have identified a new PARP synthetic lethal interaction that is conserved in human cells. Our results suggest that MUS81 protection after PARP inhibitor treatment is functionally distinct from other homologous recombination repair genes and provides further insights into the mechanism behind PARP inhibitor-induced selective tumor cell killing. Citation Format: Melanie L. Bailey, Nigel J. O’Neil, Philip Hieter. Cross-species analysis identifies MUS81, a structure-specific endonuclease, as a novel synthetic lethal interaction with PARP [abstract]. In: Proceedings of the AACR Precision Medicine Series: Opportunities and Challenges of Exploiting Synthetic Lethality in Cancer; Jan 4-7, 2017; San Diego, CA. Philadelphia (PA): AACR; Mol Cancer Ther 2017;16(10 Suppl):Abstract nr A04.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.009

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0010.000
Insufficient payload (model declined to judge)0.0030.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.053
GPT teacher head0.356
Teacher spread0.303 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2017
Admission routes1
Has abstractyes

Explore more

Same venueMolecular Cancer TherapeuticsSame topicPARP inhibition in cancer therapyFrench-language works237,207